|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.7 SEK | +1.48% |
|
+14.17% | +72.33% |
| Apr. 25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Jan. 29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Arcoma AB reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was SEK 21.21 million compared to SEK 30.25 million a year ago. Revenue was SEK 21.92 million compared to SEK 30.74 million a year ago.
Net loss was SEK 7.28 million compared to SEK 5.89 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +72.33% | 16.24M | |
| -5.77% | 14.6B | |
| -40.71% | 2.71B | |
| -12.92% | 2.44B | |
| -8.78% | 1.51B | |
| -.--% | 1.12B | |
| +40.66% | 518M | |
| +12.41% | 239M | |
| +1.67% | 183M | |
| -.--% | 168M |
ARCOMA AB 
